Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

The $139 billion TAMP has hired industry veteran Phil Rogerson, unveils $10 million commitment for strategic expansion in ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

A new startup offering an AI-enabled threat-hunting platform is emerging from stealth today with backing from Bain Capital ...

Nebulock was created to solve a glaring problem: organizations outside the Fortune 100 lack the resources and skills for proactive threat hunting. Threat hunting workflows take weeks to execute, and ...

The $139 billion TAMP has hired industry veteran Phil Rogerson, unveils $10 million commitment for strategic expansion in ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

TH Global Capital, an award-winning global boutique investment banking firm recognized as Boutique Investment Banking Firm of the Year by The M&A Advisor for three consecutive years, with a track ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

The increasing appeal of the German market was evidenced this week with the news that PE firm Bridgepoint is close to signing ...